← Leaderboards
Katherine Sullivan Reed
Temple Univ Of The Commonwealth
$58,858
Attributed
$58,858
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $29.7K · FY2016–17$50K$37.5K$25K$12.5K$0
'16
'17
Funding mix
By agency
NIH$58,858 · 1
By mechanism
F31$58,858 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Tomasz Skorski$21,974,892
- Alexander V Mazin$9,841,805
- Richard T Pomerantz$13,012,287
- Yuri Persidsky$27,976,914
- Ho-Lun Wong$3,857,053
Others in their field
Top investigators on “Addiction”
- Wafaa M. El-Sadr · Columbia University Health Sciences$122,006,808
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Jeffrey H Samet · Boston University Medical Campus$108,787,548
- Myron S Cohen · Family Health International$101,800,876
- Sharon L. Walsh · University Of Kentucky$92,602,816
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$89,041,364
Research focus
AddictionAffectApoptosisAptamerBackBaseBrca1 GeneBrca2 GeneCancer CellCell DeathCellsClinical ApplicationClinical TrialsCytotoxicCytotoxic AgentCytotoxic ChemotherapyDefectDetectionDna BindingDna Binding DomainDna Double Strand BreakDna LesionDna RepairAcute Myelocytic Leukemia
Grant awards (2)
Targeting PARP and RAD52 to induce "dual synthetic lethality" in leukemia patients identified by gene expression and mutation profiling$29,663
F31 · FY2017 · CA · contact PI
Targeting PARP and RAD52 to induce "dual synthetic lethality" in leukemia patients identified by gene expression and mutation profiling$29,195
F31 · FY2016 · CA · contact PI